近日,石药创新制药股份有限公司发布了截至 2024 年 12 月 31 日的年度业绩预告。公告显示,公司预计归属于上市公司股东的净利润为 4500 万元至 6600 万元,同比下降 84.81%至 89.64%;扣除非经常性损益后的净利润预计为 3800 万元至 5600 万元,同比下降 92.47%至 94.89%。从正面来看,石药创新在研发方面持续投入并取得了重要进展。报告期内,公司多款在研...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.